跳至主要内容
临床试验/CTRI/2018/10/015955
CTRI/2018/10/015955尚未招募未知

PREvention of DELirium in Intensive Care using low dose risperidone prophylaxis: a randomised placebo controlled trial (PREDELIC trial) - PREDELIC

Christian Medical College Vellore0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients admitted to the medical intensive care unit

排除标准

  • No informed consent obtained
  • Neurological disease(including post-cardiac arrest patients)
  • Come due to drug overdose
  • Alcohol withdrawal
  • Antipsychotic therapy in the last 30 days
  • Pregnancy or breast feeding
  • Documented delirium prior to IUD admission
  • Difficulty in CAM ICU assessment (serious auditory or visual disorders, mentally disabled)
  • Expected ICU stay less than 1day
  • Moribund and not expected to survive 2 days
  • Known risperidone allergy
  • Severe hemodynamic instability requiring vasopressors more the 20mcg/min
  • Renal failure eGFR less than 30ml/min
  • Liver failure child Pugh B/C

研究者

发起方
Christian Medical College Vellore

相似试验